← Leaderboards
John P Manis
Boston Children'S Hospital
$11,925,639
Attributed
$11,925,639
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,925,639 · 9
By mechanism
P01$5,193,591 · 3
R01$2,227,195 · 1
T32$1,895,282 · 1
R21$1,400,680 · 3
OT2$1,208,891 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Frederick W Alt$34,429,281
- Elliott Jennings Hagedorn$1,526,861
- Daniel Evan Bauer$19,160,492
- Jill L De Jong$1,228,925
- Ben Adam Croker$3,608,646
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTransfusionGenerationsCellsBaseCostTransplantationAffectRegimenProgramsInsightBlood CellsStem CellsMouse ModelBreedingIn VitroHuman DiseaseResourcesResearch PersonnelEnsureB-LymphocytesFundingAnimalsAnimal Model
Grant awards (28)
Transfusion Biology and Cellular Therapies$511,950
T32 · FY2025 · HL · contact PI
Transfusion Biology and Cellular Therapies$305,829
T32 · FY2024 · HL · contact PI
Normalization of Sickle Cell Disease bone marrow niche defects by RBC transfusion$858,450
P01 · FY2023 · HL · contact PI
Transfusion Biology and Cellular Therapies$654,167
T32 · FY2023 · HL · contact PI
Normalization of Sickle Cell Disease bone marrow niche defects by RBC transfusion$858,450
P01 · FY2022 · HL · contact PI
Transfusion Biology and Cellular Therapies$423,336
T32 · FY2021 · HL · contact PI
Immune repertoire and function in typical and atypical SCID$441,589
R01 · FY2020 · AI · contact PI
Animal Core$337,231
P01 · FY2020 · HL · contact PI
Acoustic separation of peripheral blood for cellular therapy of sickle cell anemia$238,807
R21 · FY2020 · HL · contact PI
Sickle Cell Disease Stem Cell Repository$1,208,891
OT2 · FY2019 · HL · contact PI
Immune repertoire and function in typical and atypical SCID$441,589
R01 · FY2019 · AI · contact PI
Animal Core$337,231
P01 · FY2019 · HL · contact PI
Acoustic separation of peripheral blood for cellular therapy of sickle cell anemia$302,130
R21 · FY2019 · HL · contact PI
Immune repertoire and function in typical and atypical SCID$441,589
R01 · FY2018 · AI · contact PI
Animal Core$330,487
P01 · FY2018 · HL · contact PI
Immune repertoire and function in typical and atypical SCID$441,589
R01 · FY2017 · AI · contact PI
Animal Core$337,231
P01 · FY2017 · HL · contact PI
Immune repertoire and function in typical and atypical SCID$460,839
R01 · FY2016 · AI · contact PI
Animal Core$341,281
P01 · FY2016 · HL · contact PI
Animal Core$356,826
P01 · FY2014 · HL · contact PI
Animal Core$347,097
P01 · FY2013 · HL · contact PI
Animal Core$365,669
P01 · FY2012 · HL · contact PI
Murine Model of Job's syndrome$205,811
R21 · FY2012 · AI · contact PI
Animal Core$363,048
P01 · FY2011 · HL · contact PI
Murine Model of Job's syndrome$246,499
R21 · FY2011 · AI · contact PI
Animal Core$360,590
P01 · FY2010 · HL · contact PI
DNA Damage Responses in B Cell Development$186,235
R21 · FY2010 · CA · contact PI
DNA Damage Responses in B Cell Development$221,198
R21 · FY2009 · CA · contact PI